Updated:
King Faisal Specialist Hospital and Research Center
King Faisal Specialist Hospital and Research Center was established in 1975 in Riyadh under the ownership of the Royal Commission for Riyadh City, operating as...
King Faisal Specialist Hospital and Research Center
King Faisal Specialist Hospital and Research Center was established in 1975 in Riyadh under the ownership of the Royal Commission for Riyadh City, operating as an independent non-profit foundation. Leadership sits with CEO Dr. Majid bin Ibrahim Al Fayyadh, who also chairs the King Faisal Specialist Hospital International subsidiary, and Board Chairman Mazin A. Al Romaih, who concurrently chairs Tadawul and Banque Saudi Fransi. KFSH&RC's capital base is anchored by a portfolio of government-granted hospital campuses and commercial real estate, with confirmed sites in Riyadh, Jeddah, and Madinah, plus a commercial expansion project in North Riyadh. The institution channels deployed capital toward clinical specialties — oncology, organ transplantation, cardiovascular diseases, neurosciences, and genetic diseases — while building adjacent infrastructure through partnerships such as the Advanced Therapy Manufacturing Campus developed with Germfree Laboratories. Investment activity also extends to non-medical enduring assets, including the Gulgee Murals and Paintings collection and a Fossil and Stone Sculptures Collection housed at its Social Club. Beyond its physical plant, KFSH&RC's financial ecosystem includes the Alinma Wareef Endowment Fund and Wareef Charity, the King Faisal Specialist Hospital Foundation, which direct philanthropic capital toward patient care and research. The organization carries an independently assessed brand valuation, but it does not publicly disclose aggregate endowment assets or total deployment figures. Its operational reach spans at least four Saudi campuses, placing it among the kingdom's largest non-sovereign healthcare-dedicated endowments by facility footprint. Structurally, KFSH&RC functions less like a traditional grant-making endowment and more like an integrated healthcare delivery system whose investment returns are consumed internally — funding translational research, clinical operations, and capital projects. Its governance under the Royal Commission for Riyadh City and board leadership drawn from Saudi Arabia's financial and exchange infrastructure marks a model where healthcare asset ownership, corporate governance, and national development mandates converge under a single non-profit charter.
General information
Firm type
Endowment / Foundation
Year founded
1975
Location
Region
Middle East
Country
Saudi Arabia
City
Riyadh
Corporate office
Riyadh, Saudi Arabia
Additional offices
Jeddah, Saudi Arabia · Madinah, Saudi Arabia · North Riyadh, Saudi Arabia
Principals
Dr. Majid bin Ibrahim Al Fayyadh
Chief Executive Officer
Mazin A. Al Romaih
Chairman of the Board of Directors
Sector focus
Frequently asked questions
Who governs KFSH&RC's investment and operational decisions?
The Royal Commission for Riyadh City is the ultimate owner, and the Board of Directors — chaired by Mazin A. Al Romaih, who also leads Tadawul and Banque Saudi Fransi — provides governance. Dr. Majid bin Ibrahim Al Fayyadh serves as CEO, and also chairs the KFSH International subsidiary. Day-to-day capital allocation decisions are integrated with clinical and research leadership rather than a separately branded investment office.
Does KFSH&RC allocate to external fund managers or only direct investments?
KFSH&RC does not publicly discuss an external manager program. Its known deployment pattern is direct: owning and operating hospital campuses in Riyadh, Jeddah, and Madinah, developing a cell and gene therapy manufacturing campus with Germfree Laboratories, and holding non-medical assets such as art collections. Endowment funds flow through the Alinma Wareef Endowment Fund and Wareef Charity for mission-aligned spending.
What role does KFSH&RC's real estate play in its capital structure?
Real estate is the visible foundation. The endowment holds hospital campuses across multiple Saudi cities and a commercial expansion site in North Riyadh. These properties generate the clinical revenue that, after operations, underpins research funding — making KFSH&RC's portfolio behave more like a healthcare REIT held in perpetuity than a liquid financial endowment.
What is the Alinma Wareef Endowment Fund and how does it relate to KFSH&RC?
The Alinma Wareef Endowment Fund is a philanthropic vehicle tied to the King Faisal Specialist Hospital Foundation (Wareef Charity). It channels donor and institutional capital to support patient care and medical research at KFSH&RC. The foundation operates alongside the hospital, providing an external-facing donation mechanism that is structurally separate from the core operating budget.
Does KFSH&RC publish its endowment size or asset allocation?
No. The institution does not publicly disclose total endowment assets, deployment figures, or a detailed asset allocation. What is public is its physical footprint across Saudi Arabia, its JCI accreditation, and its partnership roster.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: